drugset / Trial / NCT00226746

Efficacy Study of Gemcitabine, Paclitaxel, and Irradiation in the Treatment of Pancreatic Cancer

NCT00226746 ↗

NaSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to find out what effects, good and bad, the chemotherapy drugs gemcitabine (Gemzar) and paclitaxel (Taxol) have in combination with twice daily radiation treatment on locally advanced pancreatic cancer.

Timeline

Start
2003-03
Primary completion
2010-06
Completion
2012-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Gemcitabine Small molecule 75 mg/m2 —
Subject Paclitaxel Small molecule 60 mg/m2 Intravenous